Cargando…
Outcomes of trimethoprim/ sulfamethoxazole treatment for ocular toxoplasmosis in Congolese patients
BACKGROUND: Ocular toxoplasmosis (OT) is the leading cause of infectious posterior uveitis in several areas worldwide. The combination of Trimethoprim/Sulfamethoxazole (TMP/SMX) has been presented as an attractive alternative to the “classic’ treatment therapy (Pyrimethamine/Sulfadiazine). METHODS:...
Autores principales: | Nsiangani Lusambo, Nadine, Kaimbo Wa Kaimbo, Dieudonné, Ngoyi Mumba, Dieudonné Mumba, de-la-Torre, Alejandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617208/ https://www.ncbi.nlm.nih.gov/pubmed/37907920 http://dx.doi.org/10.1186/s12886-023-03183-x |
Ejemplares similares
-
Risk factors for ocular toxoplasmosis among uveitis patients in Kinshasa, DR Congo
por: Nsiangani Lusambo, Nadine, et al.
Publicado: (2023) -
A CATT Negative Result after Treatment for Human African Trypanosomiasis Is No Indication for Cure
por: Lejon, Veerle, et al.
Publicado: (2010) -
100% N(4)-acetyl-sulfamethoxazole stone induced by Trimethoprim-Sulfamethoxazole in an HIV patient being treated for toxoplasmosis
por: DeMasi, Matthew S., et al.
Publicado: (2020) -
Diabetes and intermediate hyperglycaemia in Kisantu, DR Congo: a cross-sectional prevalence study
por: Muyer, Muel Telo, et al.
Publicado: (2012) -
Sulfamethoxazole-Trimethoprim and Hyperkalemia in an Infant
por: Hudzik, Samantha A., et al.
Publicado: (2020)